These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9212218)
1. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Muzeau F; Fléjou JF; Thomas G; Hamelin R Int J Cancer; 1997 Jul; 72(1):27-30. PubMed ID: 9212218 [TBL] [Abstract][Full Text] [Related]
2. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Barrett MT; Sanchez CA; Galipeau PC; Neshat K; Emond M; Reid BJ Oncogene; 1996 Nov; 13(9):1867-73. PubMed ID: 8934532 [TBL] [Abstract][Full Text] [Related]
3. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Wong DJ; Barrett MT; Stöger R; Emond MJ; Reid BJ Cancer Res; 1997 Jul; 57(13):2619-22. PubMed ID: 9205067 [TBL] [Abstract][Full Text] [Related]
4. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443 [TBL] [Abstract][Full Text] [Related]
5. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines. Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637 [TBL] [Abstract][Full Text] [Related]
6. The MTS1 gene is frequently mutated in primary human esophageal tumors. Zhou X; Tarmin L; Yin J; Jiang HY; Suzuki H; Rhyu MG; Abraham JM; Meltzer SJ Oncogene; 1994 Dec; 9(12):3737-41. PubMed ID: 7970734 [TBL] [Abstract][Full Text] [Related]
7. MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Liu Q; Yan YX; McClure M; Nakagawa H; Fujimura F; Rustgi AK Oncogene; 1995 Feb; 10(3):619-22. PubMed ID: 7845688 [TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. González MV; Artímez ML; Rodrigo L; López-Larrea C; Menéndez MJ; Alvarez V; Pérez R; Fresno MF; Pérez MJ; Sampedro A; Coto E J Clin Pathol; 1997 Mar; 50(3):212-7. PubMed ID: 9155671 [TBL] [Abstract][Full Text] [Related]
10. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor. Raffel C; Ueki K; Harsh GR; Louis DN Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990 [TBL] [Abstract][Full Text] [Related]
11. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
12. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. Suzuki H; Zhou X; Yin J; Lei J; Jiang HY; Suzuki Y; Chan T; Hannon GJ; Mergner WJ; Abraham JM Hum Mol Genet; 1995 Oct; 4(10):1883-7. PubMed ID: 8595411 [TBL] [Abstract][Full Text] [Related]
13. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Liu Q; Neuhausen S; McClure M; Frye C; Weaver-Feldhaus J; Gruis NA; Eddington K; Allalunis-Turner MJ; Skolnick MH; Fujimura FK Oncogene; 1995 Mar; 10(6):1061-7. PubMed ID: 7700630 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
15. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Ueki K; Rubio MP; Ramesh V; Correa KM; Rutter JL; von Deimling A; Buckler AJ; Gusella JF; Louis DN Hum Mol Genet; 1994 Oct; 3(10):1841-5. PubMed ID: 7849711 [TBL] [Abstract][Full Text] [Related]
16. Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas. Esteve A; Martel-Planche G; Sylla BS; Hollstein M; Hainaut P; Montesano R Int J Cancer; 1996 May; 66(3):301-4. PubMed ID: 8621247 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029 [TBL] [Abstract][Full Text] [Related]
18. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379 [TBL] [Abstract][Full Text] [Related]
19. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Mori T; Miura K; Aoki T; Nishihira T; Mori S; Nakamura Y Cancer Res; 1994 Jul; 54(13):3396-7. PubMed ID: 8012957 [TBL] [Abstract][Full Text] [Related]
20. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Caldas C; Hahn SA; da Costa LT; Redston MS; Schutte M; Seymour AB; Weinstein CL; Hruban RH; Yeo CJ; Kern SE Nat Genet; 1994 Sep; 8(1):27-32. PubMed ID: 7726912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]